Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer.
Sun, Hongzan; Xin, Jun; Lu, Zaiming; Wang, Ning; Liu, Ning; Guo, Qiyong.
Cell Physiol Biochem
; 32(5): 1528-40, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24335178
Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.
Genomic characterization of cervical cancer based on human papillomavirus status.
MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
State of the science in cervical cancer: where we are today and where we need to go.
Intra- and inter-laboratory agreement of the FAM19A4/mir124-2 methylation test: Results from an international study.
[Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells].
LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
DNA methylation regulated microRNAs in human cervical cancer.
Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.